STAT+: Pharmalittle: We’re reading about FDA OK for a lung disease drug, pharma sales in China, and more
Written by
STAT News
Published
0
comments
0
min
Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to a potential multibillion-dollar product